Epidemiology, classification, and modifiable risk factors of peripheral arterial disease

References

• AndersonPLGelijnsAMoskowitzAUnderstanding trends in inpatient surgical volume: vascular intervention, 1980–2000J Vasc Surg200491200815192558
   PubMedGoogle Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patientsBMJ2002324718611786451
   PubMed Web of Science ®Google Scholar
• AronowWSNayakDWoodworthSEffect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatmentAm J Cardiol200392711212972114
   PubMed Web of Science ®Google Scholar
• AthyrosVGMikhailidisDPPapageorgiouAAMETS-GREECE Collaborative GroupPrevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre StudyCurr Med Res Opin200420169170115587481
   PubMed Web of Science ®Google Scholar
• BhattDREACH (Reduction of Atherothrombosis for Continued Health) registry2005American College of Cardiology Annual Scientific SessionMarch 8, 2005
   Google Scholar
• BhattDLFoxKAHackeWCHARISMA InvestigatorsClopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events (CHARISMA) trialN Engl J Med200635417061716531616
   PubMed Web of Science ®Google Scholar
• CAPRIE Steering CommitteeA randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)Lancet19963481329398918275
   PubMed Web of Science ®Google Scholar
• CriquiMHLangerRDFronekAMortality over a period of 10 years in patients with peripheral arterial diseaseN Engl J Med199232638161729621
   PubMed Web of Science ®Google Scholar
• CuiRIsoHYamagishiKRelationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese menEur J Cardiovasc Prev Rehabil200613243816575279
   PubMed Web of Science ®Google Scholar
• The CURE Trial InvestigatorsEffects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevationN Engl J Med200134549450211519503
   PubMed Web of Science ®Google Scholar
• DawsonDLCutlerBSHiattWRA comparison of cilostazol and pentoxifylline for treating intermittent claudicationAm J Med20001095233011063952
   PubMed Web of Science ®Google Scholar
• DormandyJHeeckLVigSThe fate of patients with critical leg ischemiaSemin Vasc Surg199912142710777241
   PubMedGoogle Scholar
• DormandyJARutherfordRBManagement of Peripheral Arterial Disease. TransAtlantic InterSociety Consensus (TASC)J Vasc Surg200031Suppl 1 pt 2129610642703
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• GorterPMOlijhoekJKvan der GraafYSMART Study GroupPrevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysmAtherosclerosis2004173363915064114
   PubMed Web of Science ®Google Scholar
• HamalainenHRonnemaaTHalonenJPFactors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: a population-based 7-year follow-up studyJ Intern Med19992469710310447231
   PubMed Web of Science ®Google Scholar
• HiattWRHoagSHammanRFEffect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes StudyCirculation199591147297867189
   PubMed Web of Science ®Google Scholar
• HiattWRRegensteinerJGHargartenMEBenefit of exercise conditioning for patients with peripheral arterial diseaseCirculation19908160292404633
   PubMed Web of Science ®Google Scholar
• ImparatoAMKimGEDavidsonTIntermittent claudication: its natural courseSurgery19757879591188622
   PubMed Web of Science ®Google Scholar
• JelnesRGaardstingOHougaard JensenKFate in intermittent claudication: outcome and risk factorsBr Med J (Clin Res Ed)1986293113740
   PubMedGoogle Scholar
• LuJTCreagerMAThe relationship of cigarette smoking to peripheral arterial diseaseRev Cardiovasc Med200451899315580157
   PubMedGoogle Scholar
• MarstonWADaviesSWArmstrongBNatural history of limbs with arterial insufficiency and chronic ulceration treated without revascularizationJ Vasc Surg20064410811416828434
   PubMed Web of Science ®Google Scholar
• MondilloSBalloPBarbatiREffects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular diseaseAm J Med20031143596412714124
   PubMed Web of Science ®Google Scholar
• MukherjeeDYadavJSUpdate on peripheral vascular diseases: from smoking cessation to stentingCleve Clin J Med2001687233311510529
   PubMed Web of Science ®Google Scholar
• NessJAronowWSPrevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practiceJ Am Geriatr Soc1999471255–610522961
   PubMed Web of Science ®Google Scholar
• PlanasAClaraAPouJMRelationship of obesity distribution and peripheral arterial occlusive disease in elderly menInt J Obes Relat Metab Disord20012510687011443508
   PubMed Web of Science ®Google Scholar
• PriceJFMowbrayPILeeAJRelationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery StudyEur Heart J1999203445310206381
   PubMed Web of Science ®Google Scholar
• RidkerPMStampferMJRifaiNNovel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial diseaseJAMA20012852481511368701
   PubMed Web of Science ®Google Scholar
• RossiEBiasucciLMCitterioFRisk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive proteinCirculation2002105800311854118
   PubMedGoogle Scholar
• RutherfordRBBakerJDErnstCRecommended standards for reports dealing with lower extremity ischemia: revised versionJ Vasc Surg19972651739308598
   PubMed Web of Science ®Google Scholar
• SchrorKThe pharmacology of cilostazolDiabetes Obes Metab20024Suppl 2S14912180353
   PubMed Web of Science ®Google Scholar
• SelvinEErlingerTPPrevalence of and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition survey, 1999–2000Circulation20041107384315262830
   PubMed Web of Science ®Google Scholar
• ShammasNWDippelEJEvidence-based management of peripheral vascular diseaseCurr Atheroscler Rep200573586316105478
   PubMedGoogle Scholar
• ShammasNWLemkeJHDippelEJIn-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulantJ Invasive Cardiol20031524224612730630
   PubMedGoogle Scholar
• WeitzJIByrneJClagettPDiagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical reviewCirculation1996943026498941154
   PubMed Web of Science ®Google Scholar